Sign In
Buy BGNE
$184.71
+0 (+0%)
At Close: Mar 28, 2025
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatmen
Regeneron Pharmaceuticals (NASDAQ:REGN) versus Beigene (NASDAQ:BGNE) Head-To-Head Contrast
05:22am, Thursday, 09'th Apr 2020
Regeneron Pharmaceuticals (NASDAQ:REGN) and Beigene (NASDAQ:BGNE) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuat
Norges Bank Invests $67.45 Million in Beigene Ltd (NASDAQ:BGNE)
12:42pm, Wednesday, 08'th Apr 2020
Norges Bank purchased a new position in shares of Beigene Ltd (NASDAQ:BGNE) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional
Beigene Ltd (NASDAQ:BGNE) Stock Position Raised by Bank of America Corp DE
09:46am, Saturday, 28'th Mar 2020
Bank of America Corp DE lifted its holdings in shares of Beigene Ltd (NASDAQ:BGNE) by 26.2% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Com
8 Biotech Stocks to Buy and Hold in 2020 in 2020 | MarketBeat
12:00pm, Friday, 27'th Mar 2020
We’ve identified 8 Biotech stocks that you can buy today and hold until the end of the year.
ROSEN, A HIGHLY RANKED FIRM, Continues to Investigate Securities Claims Against BeiGene, Ltd.
06:30pm, Thursday, 26'th Mar 2020
Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of BeiGene, Ltd. (NASDAQ: BGNE) resulting from allegations that BeiGen
BeiGene reports Abraxane shortage in China
01:29pm, Wednesday, 25'th Mar 2020
BeiGene (NASDAQ:BGNE) announces a supply disruption in Abraxane (nanoparticle albumin-bound paclitaxel) due to the suspension of importation instituted by the China National Medical Products Administr
BeiGene Announces Supply Update for ABRAXANE in China
01:00pm, Wednesday, 25'th Mar 2020
BEIJING, China, and CAMBRIDGE, Mass., March 25, 2020 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercia
Hedge Funds Mistimed Their Textron Inc. (TXT) Purchases
09:15pm, Thursday, 19'th Mar 2020
Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted
Hedge Funds Have Never Been More Bullish On FactSet Research Systems Inc. (FDS)
09:10pm, Thursday, 19'th Mar 2020
Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted
Is Formula One Group (FWONA) Going to Burn These Hedge Funds?
09:10pm, Thursday, 19'th Mar 2020
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
Hedge Funds Are Betting On BeiGene, Ltd. (BGNE)
09:09pm, Thursday, 19'th Mar 2020
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
7 Biotech Stocks to Buy and Hold in 2020
02:31pm, Monday, 16'th Mar 2020
Biotech stocks pulled off an impressive rally to finish 2019 strong. These names in the industry are looking to do the same in 2020.
Coronavirus Outbreak Could Disrupt Drug Companies’ Clinical Trials
03:31pm, Saturday, 07'th Mar 2020
It could develop into a serious long-term problem for the pharmaceutical industry, which relies on clinical trials to get new drugs to the market.
Could This Cancer Drug Developer’s Stock Make You Rich?
03:15pm, Friday, 14'th Feb 2020
Investing in this emerging cancer-focused biotech may just allow you to retire early.
